Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRCP(C), G. P.
Right arrow Articles by FRCP(C), J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRCP(C), G. P.
Right arrow Articles by FRCP(C), J. M.
NEUROLOGY 1992;42:1663
© 1992 American Academy of Neurology

Sensory and motor components of the restless legs syndrome

G. Pelletier FRCP(C), MD, D. Lorrain, PhD and J. Montplaisir FRCP(C), MD, PhD

Centre d'étude du sommeil, Hôpital du Sacré-Coeur, and the Université de Montréal, Montréal, Québec, Canada.

The restless legs syndrome (RLS) is characterized by two major manifestations: dysesthesias in the legs and irresistible leg movements. We developed a procedure to quantify these manifestations, and we studied their temporal interrelationships. We found that many dysesthesias may either closely precede or follow occurrences of EMG-defined leg activity, or both manifestations may occur independently. These results suggest that the sensory and motor components of RLS may represent two distinct manifestations of a common basic neurologic defect.

Supported by the Fonds de la Recherche en Santé du Québec and the Medical Research Council of Canada.

Received November 20, 1991. Accepted for publication in final form February 6, 1992.

Address correspondence and reprint requests to Dr. Jacques Montplaisir, Centre d'étude du sommeil, Hôpital du Sacré-Coeur, 5400 boul. Gouin Ouest, Montréal, PQ, Canada H4J 1C5.




This article has been cited by other articles:


Home page
 BrainHome page
S. von Spiczak, A. L. Whone, A. Hammers, M.-C. Asselin, F. Turkheimer, T. Tings, S. Happe, W. Paulus, C. Trenkwalder, and D. J. Brooks
The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study
Brain, April 1, 2005; 128(4): 906 - 917.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. Garcia-Borreguero, P. Odin, and C. Serrano
Restless legs syndrome and PD: A review of the evidence for a possible association
Neurology, September 23, 2003; 61(90063): S49 - 55.
[Abstract] [Full Text]

Home page
 NeurologyHome page
D. Garcia-Borreguero, O. Larrosa, Y. de la Llave, K. Verger, X. Masramon, and G. Hernandez
Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study
Neurology, November 26, 2002; 59(10): 1573 - 1579.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
F. Gemignani, A. Marbini, G. Di Giovanni, S. Salih, and M. G. Terzano
Charcot-Marie-Tooth disease type 2 with restless legs syndrome
Neurology, March 1, 1999; 52(5): 1064 - 1064.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
S. T. O'Keeffe
Restless Legs Syndrome: A Review
Arch Intern Med, February 12, 1996; 156(3): 243 - 248.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by AAN Enterprises, Inc.